Yuwell Anytime app analytics for August 4

Jurisdiction Statement: In accordance with Regulation (EU) 2017/745 (MDR), this application and its accompanying Continuous Glucose Monitoring System (CGMS) have been approved for use in all European Union member states, including but not limited to Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden. Furthermore, Iceland, Liechtenstein, Switzerland, and Türkiye also accept the MDR as the market access standard for medical devices. We are committed to providing users with health monitoring services that comply with international standards. In addition to complying with the CE-MDR certification, our product is actively sold within EU countries. Moreover, the CE-MDR certification is recognized as a reference standard for market access in the following countries, where we have established a sales network through local distributors: Algeria, Bolivia, Bosnia and Herzegovina, Brazil, Costa Rica, Croatia, Dominica, Dominican Republic, Egypt, El Salvador, Estonia, Guatemala, Indonesia, Libya, Lithuania, Maldives, Malta, Mexico, Montenegro, Myanmar, Nepal, Nigeria, Panama, Peru, Qatar, Romania, Serbia, Switzerland, Tunisia, Türkiye, United Arab Emirates, and New Zealand. Concurrently, we have obtained official authorization from local regulatory authorities in the following countries: United Kingdom, Argentina, Australia, India, Kazakhstan, Kyrgyzstan, Ecuador, Philippines, Russia, Saudi Arabia, South Africa, Vietnam, Armenia, Colombia, Honduras, Malaysia, Morocco, Sri Lanka, Thailand, Türkiye, Georgia, Uruguay, Uzbekistan, Iraq, Venezuela, and Chile. Product Introduction: The Anytime APP, serving as the dedicated receiving terminal for the Continuous Glucose Monitoring System (CGMS), can be downloaded and installed on your personal mobile device from the app store. This application seamlessly integrates with our high-precision sensors and transmitters, offering you an unparalleled blood glucose management experience. The Anytime APP provides the following core features: • Real-time Blood Glucose Monitoring: Check your blood glucose levels anytime, anywhere, ensuring prompt awareness of any changes. • Data Storage and Analysis: The application automatically records and stores your blood glucose data, providing detailed analytical reports to help you better understand your glycemic status. • Data Export: Enables easy sharing of your blood glucose data with your doctor or healthcare manager anytime, anywhere, facilitating the development of more personalized health management plans. Disclaimer: The Anytime APP is not intended for the diagnosis or screening of diabetes and cannot replace the advice of professional medical personnel. Any questions regarding your health condition should be directed to your physician or other qualified healthcare professionals. If your readings are too high or too low, or if you experience other diabetes-related changes in your physical condition, you should follow the routine guidelines provided by your doctor or other medical professionals. The Anytime APP does not provide medical services and is not responsible for notifying your physician or other healthcare providers of any changes in your readings.